Characterization of intracellular calcium mobilization by bombesin- related neuropeptides in PC-3 human prostate cancer cells

Prostate

Volumn 31, Issue 1, 1997, Pages 53-60

  Han, Kehan ^a   Viallet, Jean ^a   Chevalier, Simone ^a   Zheng, Wei ^a   Bazinet, Michel ^a   Aprikian, Armen G ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

bombesin; calcium mobilization; PC 3; prostate cancer

Indexed keywords

ALYTESIN; BOMBESIN; CALCIUM ION; GASTRIN RELEASING PEPTIDE; LITORIN; NEUROMEDIN B; NEUROPEPTIDE; RANATENSIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; DESENSITIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY MECHANISM; STIMULUS RESPONSE;

BOMBESIN; CALCIUM; DRUG SYNERGISM; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030976086     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970401)31:1<53::AID-PROS9>3.0.CO;2-J     Document Type: Article

References (28)

1. Boring CC, Squires TS, Tong TMS, Montgomery BA: Cancer Statistics. CA 44:7-26, 1994.
2. di Sant' Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268, 1992.
3. Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE: Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 71:3952-3965, 1993.
4. Aprikian AG, Cordon-Cardo C, Fair WR, Zhang ZF, Bazinet M, Hamdy SM, Reuter VE: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol 151:914-919, 1994.
5. Abrahamsson PA, Falkmer S, Fait K, Grimelius L: The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker:* Pathol Res Pract 185:373-380, 1989.
6. Logothetis C, Hoosein N: The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma. J Cell Biochem 16H:128-134, 1992.
7. Hoosein NM, Logothetis C, Chung LWK: Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 149:1209-1213, 1993.
8. Seghal I, Powers S, Huntley B, Powis G, Pittelkow M, Maihle NJ: Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci USA 91:4673-4677, 1994.
9. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 318:823-826, 1985.
10. Viallet J, Minna J: Gastrin-releasing peptide (GRP, mammalian bombesin) in the pathogenesis of lung cancer. Prog Growth Factor Res 1:89-97, 1989.
11. Frankel A, Tsao MS, Viallet J: Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells. Cancer Res 54:1613-1616, 1994.
12. Nelson J, Donnelly M, Walker B, Gray J, Shaw C, Murphy RF: Bombesin stimulates proliferation of human breast cancer cells in culture. Br J Cancer 63:933-936, 1991.
13. Patel KV, Schrey MP: Activation of inositol phospholipid signalling and calcium efflux in human breast cancer cells by bombesin. Cancer Res 50:235-239, 1990.
14. Schrey MP, Patel KV, Tezapsidis N: Bombesin and glucocorticoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res 52:1786-1790, 1992.
15. Narayan S, Guo, JS, Townsend CM, Singh P: Specific binding and growth effects of bombesin-related peptides on mouse colon cancers in vitro. Cancer Res 50: 6772-6778, 1990.
16. Radulovic S, Miller G, Schally AV: Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin-releasing peptide antagonist (RC-3095). Cancer Res 51:6006-6009, 1991.
17. Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63:1714-1720, 1989.
18. 6]-LH-RH and somatostatin analog RC-160. Prostate 20:269-280, 1992.
19. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER: Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 59:5-24, 1988.
20. Bunn Jr PA, Dienhart DG, Chan D, Puck TT, Tagawa M, Jewett PB, Brounschweiger E: Neuropeptide stimulation of calcium flux in human lung cancer cells: Delineation of alternative pathways. Proc Natl Acad Sci USA 87:2162-2166, 1990.
21. Rozengurt E: Early signals in the mitogenic response. Science 234:161-166, 1986.
22. Heikkila R, Trepel JB, Cuttitta F, Neckers LM, Sausville EA: Bombesin-related peptides induce calcium mobilization in a subset of human small cell lung cancer cell lines. J Biol Chem 262:16456-16460, 1987.
23. Clapham DE: Calcium signaling. Cell 80:259-268, 1995.
24. Berridge M: Inositol trisphosphate and calcium signaling. Nature 361:315-325, 1993.
25. 125I-(Tyr4)-Bombesin by tumor cells. Prostate 25:29-38, 1994.
26. Aprikian AG, Han K, Chevalier S, Bazinet M, Viallet J: Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells. J Molecular Endocrinology 16:297-306, 1996.
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985.
28. Millar JBA, Rozengurt E: Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. J Biol Chem 265:12052-12058, 1990.